Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Refarmed Chemicals presents Emedastine Difumarate, an exemplary antihistamine pharmaceutical agent meticulously designed to grant symptomatic relief for individuals battling allergic conjunctivitis. As a testament to its efficacy, Emedastine Difumarate operates as a selective blocker of histamine H1 receptors, adeptly preventing the histamine-induced dilation of blood vessels and curbing mast cell degranulation. Crafted as an ophthalmic solution, the medicine should be administered with precision—1 drop into each affected eye, twice daily—to ensure optimal results. The product is characterized by its white to yellowish powder form, testament to its purity and the high standards of manufacturing. Typically soluble in water and sparsely soluble in anhydrous ethanol, the product maintains a clean and uncolored appearance in the solution with a pH range carefully maintained between 3.0 to 4.5. In compliance with rigorous industry standards, Emedastine Difumarate proudly bears EU GMP certification, guaranteeing its production under the highest quality management protocols. Furthermore, it is crucial to note that the product is strictly contraindicated for individuals with known hypersensitivity to its components and should be avoided by those with narrow-angle glaucoma. Utilization of Emedastine Difumarate may lead to temporary blurred vision and other minor visual disturbances; hence, caution is advised while engaging in tasks necessitating sharp vision post-application. Moreover, it's celebrated for its well-tolerated nature, with minimal side effects, predominantly confined to the ocular region such as itching or burning sensations, and less commonly systemic effects like headache or fatigue. Our product ensures a safe storage parameter within room temperature (20-25°C) and gives due attention to light protection, thereby maintaining its integrity. With Emedastine Difumarate, Refarmed Chemicals delivers an established, profound solution for alleviation from the discomfort caused by allergic conjunctivitis, steering toward better ocular health for patients worldwide.

Products still subject to third-party patent protection might be available solely for R&D purposes.

REFARMED CHEMICALS proudly introduces Levetiracetam, a versatile antiepileptic medication essential for the management of seizure disorders. This innovative product is formulated to provide relief for individuals suffering from partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. Recommended for both adults and children, Levetiracetam is an indispensable pharmaceutical geared towards enhancing the quality of life for patients aged 6 years and older. Crafted with utmost precision, Levetiracetam is available in tablets, oral solution, and intravenous solution, delivering flexibility and convenience in administration. The active ingredient binds to synaptic vesicle protein 2A within the brain, mitigating the release of neurotransmitters that incite seizures, thereby providing effective seizure control with a reliable and targeted mechanism of action. REFARMED CHEMICALS, a global pharmaceutical leader situated in Mexico City, adheres to the highest standards of quality and efficacy. With rigorous certifications, including GMP and WC, our Levetiracetam meets and exceeds industry specifications. The product presents as a white or almost white powder, demonstrating high solubility in water among other solvents, ensuring ease of formulation into various dosages. While side effects such as somnolence, asthenia, and dizziness can occur, Levetiracetam remains a top choice for patients and healthcare providers alike. The prudent approach to treatment involves discussing potential interactions with other medications and considering precautions, particularly for those with kidney conditions. Our commitment to delivering high-caliber, affordable medical solutions is unrivaled. Levetiracetam from REFARMED CHEMICALS, both in generic and brand formulations, signifies our dedication to empowering healthcare professionals and patients with reliable, accessible, and high-quality therapeutic options. Trust in REFARMED CHEMICALS – your partner in progressive healthcare solutions.

Products still subject to third-party patent protection might be available solely for R&D purposes.

**Product Overview: Febuxostat – A Robust Solution for Gout Management** Refarmed Chemicals presents Febuxostat, a meticulously prepared medication aimed at alleviating the pain and discomfort associated with gout. Made from a refined white powder, Febuxostat stands out in the pharmaceutical industry as a Xanthine Oxidase Inhibitor, crucial for managing hyperuricemia and recurrent gout attacks. Structured to meet corporate expectations, Febuxostat is a testament to Refarmed Chemicals' 30-year expertise in delivering quality generic and branded medications. Manufactured in compliance with strict guidelines, including the Drug Master File (DMF) and certifications such as WC and GMP, this product is a model of reliability and efficacy. Febuxostat's fundamental use is to decrease blood uric acid levels, offering those afflicted with gout a pathway to recovery by preventing acute flare-ups, and mitigating inflammation and pain in the joints. As a white, soluble powder, Febuxostat is highly soluble in DMSO and slightly soluble in methanol and water, simplifying its integration into diverse medical formulations. Clinical trials have informed a standard starting dosage of 40 mg, adjustable up to 80 mg based on individual patient requirements and the severity of symptoms. In its commitment to patient welfare, Refarmed Chemicals underlines potential side effects ranging from nausea and headaches to rashes, ensuring informed usage of Febuxostat. In alignment with our promise of transparency and safety, we advise consulting healthcare professionals for precise diagnotics and treatment plans. Furthermore, users should be attentive to contraindications, noting that Febuxostat is unsuitable for patients with severe liver or kidney disease, or for women who are pregnant or breastfeeding. Refarmed Chemicals' Febuxostat exceeds industry standards with its impressive assay value of 98.0% - 102.0% purity and a precise control of impurities, ensuring that the product meets stringent quality criteria. The company's analytical rigor is reflected in the detailed specification of residual solvents such as Acetone, Ethanol, and Isopropanol. In the journey to deliver improved health outcomes, Refarmed Chemicals' Febuxostat is more than just a medication; it symbolizes our dedication to quality, safety, and corporate responsibility in the global pharmaceutical landscape. [*Note: Product image depicts a detailed specification chart for Febuxostat, reiterating its quality and compositions.*]

Products still subject to third-party patent protection might be available solely for R&D purposes.